CompletedNCT02731612
Lurasidone for Cognitive Symptoms in Bipolarity
About this title
Read the official source — NCT02731612This study evaluated the effectiveness of lurasidone for people with bipolarity.
Medication studyAges 19–65Multiple countries
Understand this study
What did researchers investigate?
This study evaluated the effectiveness of lurasidone for people with bipolarity.
Who was this study for?
Listed age limits: 19 years to 65 years.
- Listed locations
- Boston and 8 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: May 8, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 100
- Sponsor
- Lakshmi N Yatham
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Canada, United Kingdom, ...
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT02731612
- Official title
Show the full official title
A 6-Week Randomised, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston, United States · Cleveland, United States · Vancouver, Canada
6 more locations
- Kitakyushu, Japan
- Moriguchi-shi, Japan
- Kita-ku, Japan
- Kodaira, Japan
- Aichi, Japan
- London, United Kingdom
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the effectiveness of lurasidone for people with bipolarity.
Who is behind this study?
The study sponsor is Lakshmi N Yatham.
Did this study involve medication?
Yes. The study involved medication, including lurasidone.
Who was this study for?
Listed age limits: 19 years to 65 years.
